|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 177.42 EUR | -0.39% |
|
-0.24% | +18.32% |
| 07-30 | BMO Capital Adjusts Price Target on Biogen to $208 From $196, Maintains Market Perform Rating | MT |
| 07-30 | TD Cowen Adjusts Price Target on Biogen to $225 From $215, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | -0.39% | -0.24% | +18.32% | +62.40% | -36.06% | 29.99B |
-
|
-
|
-
|
- Stock Market
- Stocks
- BIIB Stock
- IDP Stock
- Charts Biogen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
